Proteins and Peptides
14 November 2016
Stealth BioTherapeutics Initiates Phase 1 Study of Elamipretide in Dry Age-Related Macular Degeneration14 November 2016
AFSTYLA®, for Haemophilia A, Receives Positive Opinion from European Medicines Agency CHMP14 November 2016
Catalyst Biosciences Announces Positive Preclinical Data with Subcutaneous Dosing of Coagulation Factor IX at ASH Annual Meeting14 November 2016
European Commission Approves Parsabiv™ (etelcalcetide) For The Treatment Of Secondary Hyperparathyroidism In Adults On Hemodialysis10 November 2016
Novo Nordisk submits application in the EU for including data from the two SWITCH trials in Tresiba® label10 November 2016
Halozyme Announces Broad Clinical Collaboration Agreement To Evaluate PEGPH20 And Tecentriq In Up To Eight Tumor Types9 November 2016
RegeneRx Announces First Patients Enrolled in Phase 3 U.S. Dry Eye Clinical Trial (ARISE-2 Trial) with RGN-2598 November 2016
The Medicines Company Discontinues Development of MDCO-216, its Investigational Cholesterol Efflux Promoter8 November 2016
Cerenis Therapeutics Announces Last Patient Dosed in CARAT Phase II Study with CER-001 in Post-Acute Coronary Syndrome Patients4 November 2016
Sanofi Genzyme Begins Pivotal Phase 3 Trial of NeoGAA Investigational Second-Generation Therapy for Pompe Disease4 November 2016
Nutrinia Announces First Patient Enrolled in Phase III Trial4 November 2016
Mylan and Biocon Announce Regulatory Submission for Insulin Glargine Accepted for Review by European Medicines Agency4 November 2016
Revance Announces Initiation of Phase 2 Trial of RT002 Injectable to Treat Plantar Fasciitis2 November 2016
Spyryx Biosciences Presents Data at NACFC on SPX-101 Demonstrating Efficacy, Safety, and Stability in Animal Models2 November 2016
Bremelanotide Meets Co-Primary Endpoints in Palatin’s Phase 3 Trials for Hypoactive Sexual Desire Disorder28 October 2016
The EMA Accepts to Assess the Marketing Authorization Application from PharmaMar for Aplidin27 October 2016
amcure Initiates Clinical Study in Patients to Test Novel Approach for Treating Advanced and Metastatic CancersNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports